Michael A. Hooks

937 total citations
18 papers, 682 citations indexed

About

Michael A. Hooks is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Michael A. Hooks has authored 18 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Michael A. Hooks's work include Organ Transplantation Techniques and Outcomes (7 papers), Liver Disease and Transplantation (6 papers) and Liver Disease Diagnosis and Treatment (4 papers). Michael A. Hooks is often cited by papers focused on Organ Transplantation Techniques and Outcomes (7 papers), Liver Disease and Transplantation (6 papers) and Liver Disease Diagnosis and Treatment (4 papers). Michael A. Hooks collaborates with scholars based in United States and India. Michael A. Hooks's co-authors include William J. Millikan, Michael Henderson, Robert Stahl, Alexander Duncan, John R. Galloway, Thomas F. Dodson, Michael H. Kutner, J L Chezmar, Beverly Noe and Michael Kutner and has published in prestigious journals such as Blood, Hepatology and Neurology.

In The Last Decade

Michael A. Hooks

18 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Hooks United States 13 319 298 192 75 73 18 682
H. Prestele Germany 14 273 0.9× 126 0.4× 195 1.0× 80 1.1× 78 1.1× 42 982
Nils R. Frühauf Germany 23 935 2.9× 776 2.6× 324 1.7× 59 0.8× 45 0.6× 65 1.6k
Burkhard Rodeck Germany 17 551 1.7× 316 1.1× 250 1.3× 16 0.2× 95 1.3× 56 934
Stephen Munn New Zealand 19 555 1.7× 311 1.0× 326 1.7× 70 0.9× 11 0.2× 54 1.0k
S Iwatsuki United States 20 743 2.3× 735 2.5× 426 2.2× 26 0.3× 93 1.3× 47 1.3k
J. Miller United States 18 731 2.3× 187 0.6× 139 0.7× 86 1.1× 56 0.8× 101 1.1k
Víctor Sánchez Turrión Spain 15 459 1.4× 372 1.2× 292 1.5× 34 0.5× 10 0.1× 55 816
Jorge Reyes United States 9 588 1.8× 186 0.6× 155 0.8× 29 0.4× 26 0.4× 9 953
Scott Ames United States 17 500 1.6× 175 0.6× 254 1.3× 58 0.8× 46 0.6× 33 1.3k
Nicola Cautero Italy 18 594 1.9× 445 1.5× 234 1.2× 32 0.4× 15 0.2× 82 905

Countries citing papers authored by Michael A. Hooks

Since Specialization
Citations

This map shows the geographic impact of Michael A. Hooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Hooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Hooks more than expected).

Fields of papers citing papers by Michael A. Hooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Hooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Hooks. The network helps show where Michael A. Hooks may publish in the future.

Co-authorship network of co-authors of Michael A. Hooks

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Hooks. A scholar is included among the top collaborators of Michael A. Hooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Hooks. Michael A. Hooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
LeBlanc, Thomas W., Susan Morris, Michael A. Hooks, Susan C. Locke, & Areej El‐Jawahri. (2020). Patient Experiences with Liposomal Daunorubicin and Cytarabine (CPX-351) Versus Conventional Induction Regimens: An Analysis of Patient-Reported Outcomes Data from a Prospective Trial. Blood. 136(Supplement 1). 29–30. 3 indexed citations
2.
Hooks, Michael A.. (1994). Tacrolimus, a New Immunosuppressant—A Review of the Literature. Annals of Pharmacotherapy. 28(4). 501–511. 104 indexed citations
3.
Hooks, Michael A., et al.. (1994). Vancomycin redistribution: Dosing recommendations following highflux hemodialysis. Kidney International. 45(1). 232–237. 54 indexed citations
4.
MacKay, Graham J, Michael A. Hooks, J L Chezmar, et al.. (1993). High Cardiac Output of Advanced Liver Disease Persists After Orthotopic Liver Transplantation. Survey of Anesthesiology. 37(1). 50–50. 5 indexed citations
5.
Shutter, Lori, et al.. (1993). Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. Neurology. 43(11). 2417–2417. 37 indexed citations
6.
Hooks, Michael A., Carl A. Perlino, J. Michael Henderson, William J. Millikan, & Michael Kutner. (1992). Prevalence of Invasive Cytomegalovirus Disease with Administration of Muromonab Cd-3 in Patients Undergoing Orthotopic Liver Transplantation. Annals of Pharmacotherapy. 26(5). 617–620. 15 indexed citations
7.
Henderson, J. Michael, et al.. (1992). Selective Shunt in the Management of Variceal Bleeding in the Era of Liver Transplantation. Annals of Surgery. 216(3). 248–255. 51 indexed citations
8.
Henderson, Michael, Gregory J. Mackay, Michael A. Hooks, et al.. (1992). High cardiac output of advanced liver disease persists after orthotopic liver transplantation. Hepatology. 15(2). 258–262. 73 indexed citations
9.
Stahl, Robert, J. Michael Henderson, Michael A. Hooks, Louis G. Martin, & Alexander Duncan. (1991). Therapy of the Kasabach‐Merritt syndrome with cryoprecipitate plus intra‐arterial thrombin and aminocaproic acid. American Journal of Hematology. 36(4). 272–274. 13 indexed citations
10.
Hooks, Michael A., et al.. (1991). Muromonab CD‐3: A Review of Its Pharmacology, Pharmacokinetics, and Clinical Use in Transplantation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 11(1). 26–37. 65 indexed citations
11.
Stahl, Robert, et al.. (1990). A hypercoagulable state follows orthotopic liver transplantation. Hepatology. 12(3). 553–558. 116 indexed citations
12.
Hooks, Michael A., et al.. (1989). Drug‐Induced Toxicities Associated with High‐Dose Cytosine Arabinoside Infusions. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 9(1). 23–28. 13 indexed citations
13.
Millikan, William J., J. Michael Henderson, W. Dean Warren, et al.. (1989). Change in Hepatic Function, Hemodynamics, and Morphology After Liver Transplant. Annals of Surgery. 209(5). 513–525. 32 indexed citations
14.
Henderson, Michael, et al.. (1989). Increased galactose clearance after liver transplantation: A measure of increased blood flow through the denervated liver?. Hepatology. 10(3). 288–291. 58 indexed citations
15.
Hooks, Michael A., et al.. (1989). Comparison of Whole-Blood Cyclosporine Levels Measured by Radioimmunoassay and Fluorescence Polarization in Patients Post Orthotopic Liver Transplant. Therapeutic Drug Monitoring. 11(3). 304–309. 3 indexed citations
16.
Millikan, William J. & Michael A. Hooks. (1988). Nutritional Support in Hepatic Failure. Nutrition in Clinical Practice. 3(3). 94–95. 11 indexed citations
17.
Hooks, Michael A., et al.. (1986). Nutritional Support for an Achondroplastic Dwarf: A Case Report. Journal of Parenteral and Enteral Nutrition. 10(5). 533–534. 2 indexed citations
18.
Hooks, Michael A., et al.. (1986). Recovery of phenytoin from an enteral nutrient formula. American Journal of Health-System Pharmacy. 43(3). 685–688. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Prestele Breakdown of academic impact, for papers by Nils R. Frühauf Breakdown of academic impact, for papers by Burkhard Rodeck Breakdown of academic impact, for papers by Stephen Munn Breakdown of academic impact, for papers by S Iwatsuki Breakdown of academic impact, for papers by J. Miller Breakdown of academic impact, for papers by Víctor Sánchez Turrión Breakdown of academic impact, for papers by Jorge Reyes Breakdown of academic impact, for papers by Scott Ames Breakdown of academic impact, for papers by Nicola Cautero
Rankless by CCL
2026